Astravita - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 710,168 | 781,599 | 720,700 | 807,707 | 823,293 | 876,758 | 776,267 | 765,266 |
| Profit before tax | 50,243 | 137,341 | 182,810 | 171,733 | 137,871 | 136,163 | 130,365 | 122,838 |
| Net profit | 42,707 | 116,661 | 155,200 | 145,504 | 117,190 | 115,739 | 110,810 | 103,184 |
| Equity | 597,193 | 727,459 | 802,659 | 908,163 | 845,353 | 922,871 | 980,740 | 992,086 |
| Liabilities | 42,417 | 49,419 | 52,277 | 55,492 | 44,998 | 48,523 | 30,147 | 40,860 |
| Non-current assets | 226,049 | 219,574 | 194,840 | 170,909 | 159,771 | 156,222 | 144,595 | 119,096 |
| Current assets | 412,323 | 556,242 | 659,261 | 792,076 | 729,897 | 814,477 | 865,562 | 911,726 |
| Total assets | 638,372 | 775,816 | 854,101 | 962,985 | 889,668 | 970,699 | 1,010,157 | 1,030,822 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 196,885 | 186,114 | 178,782 |
| Social insurance contributions | - | - | - | - | - | 24,169 | 23,203 | 25,193 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +11.2% | +10.1% | -7.8% | +12.1% | +1.9% | +6.5% | -11.5% | -1.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.7% | 15.0% | 18.2% | 15.1% | 13.2% | 11.9% | 11.0% | 10.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 7.2% | 16.0% | 19.3% | 16.0% | 13.9% | 12.5% | 11.3% | 10.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 6.0% | 14.9% | 21.5% | 18.0% | 14.2% | 13.2% | 14.3% | 13.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.1% | 17.6% | 25.4% | 21.3% | 16.7% | 15.5% | 16.8% | 16.1% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 65,053 | 72,707 | 75,863 | 82,842 | 92,332 | 103,148 | 90,439 | 93,706 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Astravita - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-19 | 1703.56 |
| 2026-07-16 | 2026-07-17 | 1703.56 |
| 2025-06-17 | 2025-06-19 | 2064.38 |
| 2024-10-16 | 2024-10-30 | 6.58 |
| 2023-06-16 | 2023-06-27 | 16.12 |
| 2023-05-16 | 2023-06-06 | 16.12 |
| 2023-05-02 | 2023-05-03 | 2.00 |
| 2023-04-26 | 2023-04-28 | 2.00 |
| 2023-04-18 | 2023-04-25 | 1.91 |
| 2023-03-22 | 2023-04-02 | 0.93 |
| 2023-02-17 | 2023-02-21 | 43.55 |
| 2022-12-16 | 2022-12-19 | 1141.74 |
Astravita - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-11 | 2026-03-12 | 2799.19 |
| 2025-12-17 | 2025-12-29 | 5.85 |
| 2025-12-03 | 2025-12-16 | 0.62 |
| 2025-09-25 | 2025-09-30 | 9.48 |
| 2025-09-19 | 2025-09-24 | 4681.72 |
| 2025-05-08 | 2025-05-12 | 334.82 |
| 2025-02-28 | 2025-02-28 | 41.26 |
| 2025-02-20 | 2025-02-25 | 41.16 |
| 2024-12-30 | 2025-01-01 | 1.38 |
| 2024-12-19 | 2024-12-23 | 1.38 |
| 2024-09-29 | 2024-10-09 | 9.79 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Astravita, UAB (code 125902447) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €765.3K and net profit of €103.2K, with a profit margin of 13.5%. Revenue declined slightly by 1.4% year on year and by 12.7% over two years, while profit followed a similar but moderate downward trend from €115.7K in 2023 to €110.8K in 2024 and €103.2K in 2025. Despite the softer sales trend, profitability remained solid and fairly stable across the period. The balance sheet strengthened further in 2025, with total assets of €1.03M, equity of €992.1K and liabilities of €40.9K. The equity ratio stood at 96.2% and debt-to-equity at 0.04, indicating a very conservative capital structure. Return on equity was 10.4% and return on assets 10.0%, while asset turnover was 0.74x. Revenue per employee was €95.7K and profit per employee €12.9K.